FIELD: medicine.
SUBSTANCE: what is involved is an integrated pathogenetic therapy containing detralex 3 tablets two times a day (a daily dose of diosmin 2,700 mg, hesperidin 300 mg) for 4 days, then 2 tablets two times a day (a daily dose of diosmin 1,800 mg, hesperidin 200 mg) for 9 days, Trombovazim 1 tablet (800 units) 2 times a day for 15 days as a basic course, then 1 tablet (800 units) 1 time a day) 15 days as a supporting course, and a preparation of thioctic acid 600 mg intravenously in normal saline 200.0 drop-by-drop at max. 60 drops/min for 13 days, then 600 mg a day in the form of tablets for 17 days.
EFFECT: effective reduction of reperfusion syndrome in the given category of patients by increasing venous vascular tone, improving rheological blood properties and trophism of injured nerve terminals.
2 cl, 10 dwg, 9 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SYSTEM OF HELPING PEOPLE WITH SYNDROME OF DIABETIC FOOT | 2012 |
|
RU2506894C1 |
| METHOD OF TREATING NEUROPATHIC TROPHIC ULCERS ACCOMPANYING DIABETIC FOOT | 2013 |
|
RU2549459C2 |
| METHOD OF TREATING PATIENTS WITH POSTOPERATIVE LYMPHORRHEA | 2023 |
|
RU2807874C1 |
| METHOD FOR TOTAL STRIPPING OF A GREATER SAPHENOUS VEIN IN ACUTE VARICOTHROMBOPHLEBITIS OF LOWER EXTREMITIES | 2020 |
|
RU2740468C1 |
| METHOD OF TREATING PATIENTS WITH SEVERE FORMS OF REPERFUSION SYNDROME COMPLICATED BY POSTOPERATIVE LYMPHORRHEA | 2023 |
|
RU2808921C1 |
| METHOD FOR TOTAL STRIPPING OF GREATER SAPHENOUS VEIN IN VARICOSE VEINS OF LOWER EXTREMITIES | 2019 |
|
RU2726588C1 |
| COMBINED METHOD OF TREATMENT OF PATIENTS WITH CRITICAL ISCHEMIA OF LOWER EXTREMITIES | 2023 |
|
RU2808920C1 |
| METHOD OF TREATING PATIENTS WITH SEVERE FORMS OF REPERFUSION SYNDROME | 2023 |
|
RU2807877C1 |
| METHOD OF TREATING PATIENTS WITH REPERFUSION SYNDROME | 2023 |
|
RU2807876C1 |
| METHOD FOR SURGICAL TREATMENT OF CRITICAL ISCHEMIA OF LOWER EXTREMITIES WITH OCCLUSION OF SUPERFICIAL FEMORAL AND POPLITEAL ARTERIES | 2019 |
|
RU2721884C1 |
